» Authors » S Boquist

S Boquist

Explore the profile of S Boquist including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 421
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Silveira A, Carlo A, Adam M, McLeod O, Lundman P, Boquist S, et al.
Int J Lab Hematol . 2018 Jan; 40(3):251-257. PMID: 29356352
Introduction: Factor VII activation occurs postprandially. A proportion of activated factor VII (VIIa) circulates in complex with antithrombin (VIIaAT). Our primary objective was to assess the effects of postprandial lipemia...
2.
Boquist S, Ruotolo G, Skoglund-Andersson C, Tang R, Bjorkegren J, Bond M, et al.
Clin Endocrinol (Oxf) . 2007 Sep; 68(1):51-8. PMID: 17803702
Objectives: IGF-I, IGFBP-1 and IGFBP-3 are putative mediators in cardiovascular disease. The present study examined (i) the correlations of circulating IGF-I, IGFBP-1 and IGFBP-3 to established cardiovascular risk factors and...
3.
Samnegard A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, et al.
J Intern Med . 2005 Oct; 258(5):411-9. PMID: 16238676
Objectives: Matrix metalloproteinase-3 (MMP-3) is implicated in the formation of atherosclerotic plaques, and the MMP-3 -1612 5A/6A polymorphism is associated with myocardial infarction (MI) and stable coronary artery disease (CAD)....
4.
Gertow K, Bellanda M, Eriksson P, Boquist S, Hamsten A, Sunnerhagen M, et al.
J Clin Endocrinol Metab . 2004 Jan; 89(1):392-9. PMID: 14715877
Disturbances in fatty acid metabolism are involved in the etiology of insulin resistance and the related dyslipidemia, hypertension, and procoagulant state. The fatty acid transport proteins (FATPs) are implicated in...
5.
Juhan-Vague I, Morange P, Frere C, Aillaud M, Alessi M, Hawe E, et al.
J Thromb Haemost . 2003 Nov; 1(11):2322-9. PMID: 14629464
Unlabelled: Although the potential role of plasminogen activator inhibitor-1 (PAI-1) in the development of coronary artery disease is strongly supported by its biological characteristics, results of clinical studies remain controversial....
6.
Gertow K, Skoglund-Andersson C, Eriksson P, Boquist S, Orth-Gomer K, Schenck-Gustafsson K, et al.
Atherosclerosis . 2003 Jun; 167(2):265-73. PMID: 12818409
The fatty acid transport proteins (FATPs) have been implicated in facilitated cellular uptake of non-esterified fatty acids (NEFAs), thus having the potential to regulate local and systemic NEFA concentrations and...
7.
Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Karpe F, Tang R, et al.
Eur Heart J . 2002 Feb; 23(5):376-83. PMID: 11846495
Aims: Tumour necrosis factor-alpha (TNF-alpha) is a proinflammatory cytokine, which is implicated in some metabolic disorders and may play a role in the development of cardiovascular disease. We examined whether...
8.
van t Hooft F, Ruotolo G, Boquist S, de Faire U, Eggertsen G, Hamsten A
Circulation . 2001 Sep; 104(11):1223-8. PMID: 11551871
Background: Apolipoprotein (apo) A-II is a major structural protein of plasma HDLs, but little is known regarding its functions. Methods And Results: To investigate the physiological role of apoA-II in...
9.
Karpe F, Boquist S, Tang R, Bond G, de Faire U, Hamsten A
J Lipid Res . 2001 Feb; 42(1):17-21. PMID: 11160361
Remnants of triglyceride-rich lipoproteins (TRL) have been implicated in the early development of atherosclerosis. We tested this hypothesis by quantifying the plasma concentration of remnant-like particle cholesterol (RLP-C) in a...
10.
Boquist S, Hamsten A, Karpe F, Ruotolo G
Diabetologia . 2001 Feb; 43(2):185-93. PMID: 10753040
Aims/hypothesis: Enhanced and prolonged postprandial lipaemia is related to cardiovascular disease but how postprandial lipaemia is regulated is poorly known. We therefore determined the relations of fasting insulin concentrations to...